Perrigo Company plc Defined Benefit Plan, Plan Assets, Payment for Settlement
Perrigo Company plc (PRGO) reported Defined Benefit Plan, Plan Assets, Payment for Settlement of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanSettlementsPlanAssets · last filed 2022-03-01
- Perrigo Company plc defined benefit plan, plan assets, payment for settlement for fiscal 2021 was $0.00.
- Perrigo Company plc defined benefit plan, plan assets, payment for settlement for fiscal 2020 was $0.00.
- Perrigo Company plc defined benefit plan, plan assets, payment for settlement for fiscal 2019 was $0.00.
- Perrigo Company plc defined benefit plan, plan assets, payment for settlement for fiscal 2018 was $0.00.
| Period end | Defined Benefit Plan, Plan Assets, Payment for Settlement 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2018-12-31 | $0.00 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |